Search
Search
About
Log in
Join
Experiences with
Ledipasvir / Sofosbuvir
Posts
Communities
45 public posts
Filter results
Achillion, Gilead drug cocktail cures hepatitis C in six weeks
Achillion achieves 100% SVR12 in six-week regimen with combination of ACH-3102 and sofosbuvir for treatment-naïve genotype 1 HCV - Read more: http://bit.ly/1IEmNKF
Achillion achieves 100% SVR12 in six-week regimen with combination of ACH-3102 and sofosbuvir for treatment-naïve genotype 1 HCV - Read more: http://bit.ly/1IEmNKF
mwright
in
HFI Connect - Hepatitis
10 years ago
Generic drugmakers to produce cheaper version of Sovaldi
Gilead's agreement also covers another treatment, a single tablet combination of
sofosbuvir
and another antiviral drug,
ledipasvir
. Regulators in both the United States and Europe are currently reviewing that combination.
Gilead's agreement also covers another treatment, a single tablet combination of
sofosbuvir
and another antiviral drug,
ledipasvir
. Regulators in both the United States and Europe are currently reviewing that combination.
JKArmah
Pioneer
in
HFI Connect - Hepatitis
10 years ago
Update on treatment
the tablets are called
sofosbuvir
combined with
ledipasvir
as well as having ribavirin. so far treatment has been going well, first bloods will be done next week. just a reminder, my husband has liver disease and hep c genotype . will let you know what the results are of the blood tests
the tablets are called
sofosbuvir
combined with
ledipasvir
as well as having ribavirin. so far treatment has been going well, first bloods will be done next week. just a reminder, my husband has liver disease and hep c genotype . will let you know what the results are of the blood tests
pear-shaped
in
British Liver Trust
10 years ago
Want to take advantage of all our features? Just log in!
Log in
or
Join
FDA gives its seal of approval to new hep C drug
The first all-oral regimen for treating the hepatitis C virus has been approved by the US FDA. Gilead Science's sofosbuvir was given unanimous backing by the 15 members of the panel. Read our coverage of this treatment development here: http://hepatitiscnews.com/fda-panel-backs-new-hepatitis-c-drug-sofosbuvir
The first all-oral regimen for treating the hepatitis C virus has been approved by the US FDA. Gilead Science's sofosbuvir was given unanimous backing by the 15 members of the panel. Read our coverage of this treatment development here: http://hepatitiscnews.com/fda-panel-backs-new-hepatitis-c-drug-sofosbuvir
Hep_C_News_team
in
Hepatitis C Trust
11 years ago
Congratulation to people with hepatitis c Your CURED !!
(AP) – 1 day ago NEW YORK (AP) — Abbott Laboratories said Monday that its experimental hepatitis C drug regimen cured 99 percent of patients in a midstage study with the most common and hardest-to-treat type of the disease. Patients who took a three-drug regimen and the drugs Ritonavir and ribavirin
(AP) – 1 day ago NEW YORK (AP) — Abbott Laboratories said Monday that its experimental hepatitis C drug regimen cured 99 percent of patients in a midstage study with the most common and hardest-to-treat type of the disease. Patients who took a three-drug regimen and the drugs Ritonavir and ribavirin
Hidden
in
Cure Parkinson's
12 years ago
1
2
3
Filter results
Clear filters
Posted in
All communities
HFI Connect - Hepatitis
32 results
British Liver Trust
5 results
Hepatitis C Support
5 results
View top 10 communities
Sort by
Most Relevant
Newest